Literature DB >> 5086217

Detection of fibrinogen-fibrin degradation products by counterelectrophoresis.

J I Brody.   

Abstract

Counterelectrophoresis using a discontinuous buffer system permits detection of fibrinogen-fibrin degradation products (FDP) under a variety of clinical circumstances. The method is sensitive, reliable, and is easily performed using conventional equipment in any clinical laboratory assuming the responsibility for assaying fibrinogen-fibrin degradation products.

Mesh：

Substances：

Year:  1972        PMID： 5086217      PMCID： PMC477503          DOI： 10.1136/jcp.25.9.754

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  8 in total

1.  Fibrinolysin studies in hemophilia.

Authors:  J I Brody; M Mobarak; P Lau; L H Beizer
Journal:  Arch Intern Med       Date:  1966-09

2.  Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.

Authors:  J Hawiger; S Niewiarowski; V Gurewich; D P Thomas
Journal:  J Lab Clin Med       Date:  1970-01

3.  The clinical challenge of disseminated intravascular coagulation.

Authors:  D Deykin
Journal:  N Engl J Med       Date:  1970-09-17       Impact factor: 91.245

4.  A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum.

Authors:  C Merskey; P Lalezari; A J Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

5.  Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies.

Authors:  V J Marder; M O Matchett; S Sherry
Journal:  Am J Med       Date:  1971-07       Impact factor: 4.965

6.  Counterelectrophoresis for detection of hepatitis--associated antigen: methodology and comparison with gel diffusion and complement fixation.

Authors:  H J Alter; P V Holland; R H Purcell
Journal:  J Lab Clin Med       Date:  1971-06

7.  Micro starch gel electrophoresis under petroleum ether.

Authors:  J I Brody; M A Mobarak; M Haidar
Journal:  Clin Chim Acta       Date:  1967-11       Impact factor: 3.786

8.  Defibrination syndrome with defective thrombinfibrinogen reaction reversible by protamine.

Authors:  A L Bloom; N Campbell
Journal:  J Clin Pathol       Date:  1965-11       Impact factor: 3.411
  8 in total
  2 in total

1.  The production and testing of staphylococci with clumping factor activity for use in the assay of fibrinogen degradation products.

Authors:  G Richardson
Journal:  J Clin Pathol       Date:  1973-05       Impact factor: 3.411

2.  Fibrin degradation products in the serum and cerebrospinal fluid of patients with group A meningococcal meningitis.

Authors:  M J Brueton; P Tugwell; H C Whittle; B M Greenwood
Journal:  J Clin Pathol       Date:  1974-05       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.